tirzepatide cons Semaglutide & Patent Considerations Tirzepatide (Zepbound, Mounjaro): Weight Loss,

Clinical data shows that discontinuing either semaglutide or tirzepatide leads to significant weight regain in most users, often recovering two-thirds of the lost weight within one year of stopping

Packages used in the analyses included mia (v.1.8.0), dplyr (v.1.1.3), tidyr (v.1.3.0), and purrr (v.1.0.2)

The FDA has proposed permanently excluding tirzepatide (along with semaglutide and liraglutide) from large-scale 503B compounding, and on June 26, 2026 it extended the public comment deadline on that proposal from June 30 to July 30, 2026

Sleep and inflammation: partners in health and disease

Probiotics in obese pregnancy do not reduce maternal fasting glucose: A double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study)